AU1220776A - 16, 16 disubstituted androstenes - Google Patents

16, 16 disubstituted androstenes

Info

Publication number
AU1220776A
AU1220776A AU12207/76A AU1220776A AU1220776A AU 1220776 A AU1220776 A AU 1220776A AU 12207/76 A AU12207/76 A AU 12207/76A AU 1220776 A AU1220776 A AU 1220776A AU 1220776 A AU1220776 A AU 1220776A
Authority
AU
Australia
Prior art keywords
androstenes
disubstituted
disubstituted androstenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU12207/76A
Other versions
AU501246B2 (en
Inventor
F Cassidy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU1220776A publication Critical patent/AU1220776A/en
Application granted granted Critical
Publication of AU501246B2 publication Critical patent/AU501246B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU12207/76A 1975-03-21 1976-03-19 16, 16 disubstituted androstenes Expired AU501246B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB11819/75 1975-03-21
GB11819/75A GB1538227A (en) 1975-03-21 1975-03-21 16,16-disubstituted steroids of the androstene series

Publications (2)

Publication Number Publication Date
AU1220776A true AU1220776A (en) 1977-09-22
AU501246B2 AU501246B2 (en) 1979-06-14

Family

ID=9993275

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12207/76A Expired AU501246B2 (en) 1975-03-21 1976-03-19 16, 16 disubstituted androstenes

Country Status (15)

Country Link
JP (2) JPS51118756A (en)
AT (1) AT357700B (en)
AU (1) AU501246B2 (en)
BE (1) BE839751A (en)
CA (1) CA1069498A (en)
CH (2) CH621560A5 (en)
DE (1) DE2610497C2 (en)
DK (1) DK143757C (en)
FR (2) FR2304345A1 (en)
GB (1) GB1538227A (en)
IE (1) IE42308B1 (en)
IL (2) IL49132A (en)
NL (1) NL184111C (en)
SE (2) SE7603410L (en)
ZA (1) ZA761324B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602960A (en) * 1977-05-25 1981-11-18 Beecham Group Ltd Process for preparing 16,16-disubstituted steroids of the androstene series
DE2943778A1 (en) * 1979-10-26 1981-05-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17-Alpha:alkyl-4,15-androstadiene-3-one derivs. - topical antiandrogens effective against acne, seborrhoea, alopecia and hirsutism
DE3514272A1 (en) * 1985-04-17 1986-10-23 Schering AG, 1000 Berlin und 4709 Bergkamen DERMATICA
JPS63300153A (en) * 1987-05-29 1988-12-07 日本碍子株式会社 Building enamel panel
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
WO1992007586A1 (en) * 1990-10-31 1992-05-14 Beecham Group Plc Topical composition with retinoid penetration enhancer
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
AU2002357610A1 (en) * 2001-12-19 2003-06-30 Chugai Seiyaku Kabushiki Kaisha Androstane derivative having substituent in 7- and 17-positions
CN108558975B (en) * 2018-04-26 2021-03-02 昆明理工大学 12 beta-hydroxy-androstane 4, 14-diene-16-ketone compound and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853926A (en) * 1973-05-29 1974-12-10 Searle & Co 17{62 -hydroxy-16,16-dimethylester-4-en-3-one

Also Published As

Publication number Publication date
NL184111C (en) 1989-04-17
IL49132A (en) 1980-05-30
IE42308B1 (en) 1980-07-16
JPS625920B2 (en) 1987-02-07
DK143757B (en) 1981-10-05
DK143757C (en) 1982-03-22
GB1538227A (en) 1979-01-10
DK123476A (en) 1976-09-22
DE2610497A1 (en) 1976-10-07
SE7603410L (en) 1976-09-22
IL58505A0 (en) 1980-01-31
JPS6355488B2 (en) 1988-11-02
FR2304345B1 (en) 1980-11-07
SE7902256L (en) 1979-03-13
BE839751A (en) 1976-09-20
IL49132A0 (en) 1976-05-31
JPS51118756A (en) 1976-10-18
JPS61178920A (en) 1986-08-11
CA1069498A (en) 1980-01-08
ATA191376A (en) 1979-12-15
NL184111B (en) 1988-11-16
CH621560A5 (en) 1981-02-13
FR2304345A1 (en) 1976-10-15
CH631996A5 (en) 1982-09-15
DE2610497C2 (en) 1986-10-16
ZA761324B (en) 1977-02-23
AU501246B2 (en) 1979-06-14
FR2445340A1 (en) 1980-07-25
IE42308L (en) 1976-09-21
AT357700B (en) 1980-07-25
FR2445340B1 (en) 1983-02-11
NL7602949A (en) 1976-09-23

Similar Documents

Publication Publication Date Title
AU1405576A (en) 103-dihydroimidazo (4,5-6) pyridin -2-ones
AU504595B2 (en) 4,5-dihydro-2-lower-alkoxycarbonyl-amino-4 phenylimidazoles
AU498333B2 (en) 7-substituted-benzo-1, 2, 4-triazine-3-ethers
AU507882B2 (en) 1, 4-diphenyl-3-pyrazolin-5-ones
AU501246B2 (en) 16, 16 disubstituted androstenes
AU8483675A (en) Polyhydroxy-alkyl-3,5-disubstituted-2, 4,6-triiodo-carbanilates
AU500164B2 (en) 3, 4, 5-substituted benzenesulfonformamidines
AU502683B2 (en) Thiopyrano-4, 3-c-pyrazoles
AU518594B2 (en) 15, 15-dihydroxyprostaglandins
AU505725B2 (en) 2, 9-dioxatricyclo ( 4,3,1,03,70 dercanes
AU505161B2 (en) 1, 3, 5, 7-tetraaza-4-sulpha-hept-1-en-6-one derivatives
AU499442B2 (en) 1, 4 benzodioxanes
AU502268B2 (en) 2, 1, 3-benzothiadiazine compounds
AU511156B2 (en) 7, 7-Dimethylnorbornane derivatives
AU504998B2 (en) 1, 3, 5 oxadiazine derivatives
AU498671B2 (en) 1-aryl-2-oxo-hexahydro-2,4,5,6,7,7a-indoles
AU500501B2 (en) 6,11-dihydrodibenzo-thiepin-11-ones
AU506542B2 (en) 1, 3-dialkyl-7-oxoalkylxanthines
AU493823B2 (en) 1,1-diaryl-1-oxadiazol-alkylamines
AU506523B2 (en) 1, 3-Dialkyl-7-oxoalkylaxanthines
AU514608B2 (en) 3,4-substituted-azetidin-z-ones
AU506546B2 (en) 3, 20-diketopregnenes having an 11b-acetal groups
CA1032169A (en) 1,2,4-triazolidin-3-ones
CA1029373A (en) 1,2,4-dithiaaz-3-enes
AU485558B2 (en) N, n'disubstituted naphthaleneacetamidines